Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …
Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials
CM Chao, TS Weng, YH Chen, CC Lai… - Expert Review of Anti …, 2022 - Taylor & Francis
Objects This study compared the clinical efficacy and safety of anti-methicillin-resistant
Staphylococcus aureus (MRSA) quinolones for treating acute bacterial skin and skin …
Staphylococcus aureus (MRSA) quinolones for treating acute bacterial skin and skin …
[PDF][PDF] Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics 2023; 12: 557
The pathogenic bacterium Staphylococcus aureus is the most common pathogen isolated in
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …
skin-and-soft-tissue infections (SSTIs) in the United States. Most S. aureus SSTIs are caused …